II. Contraindications
- Absolute Contraindications
- Angioedema history
- Regardless of cause (even if not due to ACE Inhibitor)
- Pregnancy (serious Teratogenicity - black box warning)
- Renal Artery Stenosis
- ACE Inhibitor related Allergic Reaction
- Angioedema history
- Relative Contraindications
III. Indications
-
Hypertension
- Useless in low renin patients (esp. Black ethnicity)
- Low renin patients respond better to Diuretics
-
Myocardial Infarction
- Early ACE Inhibitor in acute Myocardial Infarction
- Started within 24 hours of Anterior MI
- Significant reduction in CHF and death
- Significantly lower mortality at 1 year
- Reference
- Early ACE Inhibitor in acute Myocardial Infarction
-
Congestive Heart Failure
- Left ventricle Systolic Dysfunction
- Diabetic Nephropathy
- Renal Insufficiency
IV. Mechanism
V. Safety
- Pregnancy: Category D
- Category C if stopped in first trimester
- Serious Teratogenicity risk to fetus if continued into second or third trimester
-
Lactation
- Unknown
- Risk of Hypotension in newborns
VI. Preparations (Choose once daily dosing if possible)
- Benzapril (Lotensin)
- Hypertension: 10 mg orally daily (target 20-40 mg/day)
- Maximum: 80 mg/day
- Renal Dosing
- GFR <30: Start at 5 mg
- Primarily renal excretion (as benzeprilat)
- Available as unscored generic tablets: 5, 10, 20 and 40 mg
- Captopril (Capoten)
- Hypertension: 25 mg orally twice to three times daily (maximum 450 mg/day)
- CHF: 6.25 - 12.5 mg orally three times daily (maximum 450 mg/day)
- Primarily Renal Dosing
- Available as scored generic tablets: 12.5, 25, 50 and 100 mg
- Enalapril (Vasotec)
- Hypertension: 5 mg orally daily (maximum 40 mg/day)
- CHF, GFR<30: 2.5 mg orally daily to twice daily (maximum 40 mg/day)
- IV (Hypertensive Emergency): 1.25 mg IV every 6 hours
- Excretion both renal and hepatic
- Available as scored tablets: 2.5, 5, 10 and 20 mg
- Fosinopril (Monopril)
- Hypertension: 10 mg orally daily (target 40 mg/day)
- CHF: 10 mg orally daily (target 20-40 mg/day)
- Renal Impairment: 5 mg orally daily at start
- Maximum: 80 mg/day
- Excretion both renal and hepatic
- Available as scored tablets (10 mg) and unscored tablets (20 and 40 mg)
- Lisinopril (Prinivil, Zestril)
- Hypertension: 10 mg orally daily (target 20-40 mg/day)
- CHF: 5 mg orally daily (target 20 mg/day)
- Acute MI: 5 mg orally daily for 2 days then 10 mg orally daily
- Renal Dosing
- GFR 10-30: 2.5 to 5 mg orally daily to start
- GFR <10: 2.5 mg orally daily to start
- Maximum 40 mg/day
- Primarily renal excretion
- Available as generic/Prinivil scored tablets (10, 20 and 40 mg)
- Available as generic/Zestril unscored tabs (2.5, 5, 10, 20, 30 and 40 mg)
- Moexipril (Univasc): Take one hour before meals
- Hypertension: 7.5 mg orally daily (maximum 30 mg/day)
- Primarily hepatic metabolism
- Available as generic scored tablets (7.5, 15 mg)
- Perindopril (Aceon)
- Hypertension: 4 mg orally daily (target 4-8 mg/day)
- Maximum 16 mg/day
- Primarily renal metabolism
- Available as generic unscored tablets (2, 4, 8 mg)
- Quinapril (Accupril)
- Hypertension: 10 mg orally daily (target 20-40 mg/day)
- CHF: 2.5 mg to 5 mg orally twice daily
- Low dose is especially important if concurrent Diuretic use
- Titrating weekly to 20-40 mg/day
- Renal Dosing
- GFR 30-60: 5 mg orally daily to start
- GFR 10-30: 2.5 mg orally daily to start
- Maximum: 80 mg/day (no benefit above 40 mg/day)
- Excretion is 50-60% renal
- Available as generic scored tablets (5 mg) and unscored tablets (10,20 and 40 mg)
- Ramipril (Altace)
- Hypertension: 2.5 mg orally daily (target 2.5-20 mg orally daily)
- CHF or MI: 2.5 mg orally twice daily (target 5 mg orally twice daily)
- Renal Impairment or Diuretic use: 1.25 mg orally daily to start
- Maximum 20 mg/day
- Excretion both renal and hepatic
- Available as generic capsule (1.25, 2.5, 5, 10 mg)
- Trandopril (Mavik)
- Hypertension: 1 mg orally daily (target 2 to 4 mg orally daily)
- CHF: 0.5 to 1 mg orally daily (target 4 mg orally daily)
- Maximum: 8 mg/day
- Excretion 66% hepatic and 33% renal
- Available as generic scored tablet (1 mg) and unscored tablet (2 and 4 mg)
VII. Adverse Effects
-
Cough (dry and irritating)
- Characteristics
- Occurs in 5 to 20% of patients
- More common in women
- More common in black patients
- Not dose related
- Stops within 4 days of medication cessation
- Occurs in 5 to 20% of patients
- Alternative medications
- Inhalers may relieve cough
- Tilade 2 puffs inhaled four times daily
- Cromolyn 20 mg inhaled four times daily
- Characteristics
-
Hyperkalemia (5% of patients)
- See Drug Interactions below
- Asociated with Renal Insufficiency, Diabetes Mellitus
-
Teratogenicity in second or third trimester
- Fetal injury or death
- Pregnancy Class C if discontinued in first trimester
-
Renal Insufficiency
- Renal Artery Stenosis (see monitoring below)
- No Creatinine level is absolute contraindication
- Baseline Serum Creatinine <3.0 mg/dl is safe
-
Hypotension
- Restart ACE Inhibitor at half prior dose
- Decrease or hold dose of any concurrent Diuretic
-
Angioedema
-
ACE inhibitor Induced Angioedema is not an Allergic Reaction (unlike typical Angioedema)
- Related to bradykinin accumulation
- Does not respond to typical Angioedema management (e.g. Corticosteroids, Antihistamines)
- Occurs in 1 of 300 patients
- More common in african american patients by factor of 2-4 fold
- Reaction can occur months to years after starting an ACE Inhibitor
- Treatment is withdrawal of medication and supportive care
- See Angioedema for management
- Reactions may be severe and life threatening with complete airway closure
- May respond to agents used for Hereditary Angioedema (e.g. Icatibant, Berinert)
- Do not re-challenge with ACE Inhibitor
- ACE Inhibitor Angioedema will recur with ARB agents in 8% of patients
- Avoid Angiotensin Receptor Blocker (ARB) unless a very compelling reason exists
- If ARB is used, wait at least 4 weeks after ACE Inhibitor has been discontinued
- Avoid using ARB in moderate to severe ACE Inhibitor Angioedema episode
-
ACE inhibitor Induced Angioedema is not an Allergic Reaction (unlike typical Angioedema)
- Rare Adverse Reactions
- Rash
- Agranulocytosis
- Neutropenia
- Associated with comorbid Renal Insufficiency
- Associated with comorbid Collagen vascular disease
VIII. Drug Interactions
- Increases Lithium levels (follow levels)
- Decreased ACE Inhibitor levels with concurrent Antacids
- Decreased Renal Function with concurrent NSAID use
- Agents predisposing to Hyperkalemia
IX. Monitoring
- Serum Potassium (if patient at risk)
-
Serum Creatinine
- Timing
- Baseline
- Recheck in 4 days to 2 weeks
- Expect an increase in Chronic Kidney Disease
- Despite this, renal protective effect outweighs mild to moderate Creatinine increase
- Indication to consider stopping ACE Inhibitor
- Serum Creatinine increased >20% in 4 days
- Additional precautions when increasing dose
- Serum Creatinine should not increase >30%
- Timing
Images: Related links to external sites (from Bing)
Related Studies
captopril (on 11/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
CAPTOPRIL 100 MG TABLET | Generic | $1.38 each |
CAPTOPRIL 12.5 MG TABLET | Generic | $0.45 each |
CAPTOPRIL 25 MG TABLET | Generic | $0.38 each |
CAPTOPRIL 50 MG TABLET | Generic | $0.68 each |
lisinopril (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
LISINOPRIL 10 MG TABLET | Generic | $0.02 each |
LISINOPRIL 2.5 MG TABLET | Generic | $0.02 each |
LISINOPRIL 20 MG TABLET | Generic | $0.02 each |
LISINOPRIL 30 MG TABLET | Generic | $0.06 each |
LISINOPRIL 40 MG TABLET | Generic | $0.05 each |
LISINOPRIL 5 MG TABLET | Generic | $0.01 each |
LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB | Generic | $0.03 each |
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB | Generic | $0.05 each |
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB | Generic | $0.05 each |
enalapril (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
ENALAPRIL 1 MG/ML ORAL SOLN | Generic | $1.89 per ml |
ENALAPRIL MALEATE 10 MG TAB | Generic | $0.11 each |
ENALAPRIL MALEATE 2.5 MG TAB | Generic | $0.10 each |
ENALAPRIL MALEATE 20 MG TAB | Generic | $0.13 each |
ENALAPRIL MALEATE 5 MG TABLET | Generic | $0.11 each |
ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET | Generic | $0.17 each |
ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB | Generic | $0.15 each |
fosinopril (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
FOSINOPRIL SODIUM 10 MG TAB | Generic | $0.17 each |
FOSINOPRIL SODIUM 20 MG TAB | Generic | $0.17 each |
FOSINOPRIL SODIUM 40 MG TAB | Generic | $0.21 each |
moexipril (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
MOEXIPRIL HCL 15 MG TABLET | Generic | $0.75 each |
MOEXIPRIL HCL 7.5 MG TABLET | Generic | $0.97 each |
perindopril (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
PERINDOPRIL ERBUMINE 4 MG TAB | Generic | $0.47 each |
PERINDOPRIL ERBUMINE 8 MG TAB | Generic | $0.50 each |
quinapril (on 2/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
QUINAPRIL 10 MG TABLET | Generic | $0.07 each |
QUINAPRIL 20 MG TABLET | Generic | $0.09 each |
QUINAPRIL 40 MG TABLET | Generic | $0.11 each |
QUINAPRIL 5 MG TABLET | Generic | $0.08 each |
QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB | Generic | $0.31 each |
QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB | Generic | $0.36 each |
QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB | Generic | $0.34 each |
ramipril (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
RAMIPRIL 1.25 MG CAPSULE | Generic | $0.09 each |
RAMIPRIL 10 MG CAPSULE | Generic | $0.07 each |
RAMIPRIL 2.5 MG CAPSULE | Generic | $0.06 each |
RAMIPRIL 5 MG CAPSULE | Generic | $0.07 each |